Diminished CD4+/CD25+ T cell and increased IFN-γ levels occur in dogs vaccinated with Leishmune® in an endemic area for visceral leishmaniasis

Veterinary Immunology and Immunopathology

Volumn 135, Issue 3-4, 2010, Pages 296-302

  de Lima, Valéria Marçal Felix ^a   Ikeda, Fabiana Augusta ^a   Rossi, Cláudio N ^a   Feitosa, Mary Marcondes ^a   de Oliveira Vasconcelos, Rosemeri ^a   Nunes, Caris Maroni ^a   Goto, Hiro ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Th1 response; Vaccine; Visceral leishmaniasis; Zoonosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LEISHMANIA VACCINE; LEISHMUNE; PROTOZOON ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BRAZIL; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LEISHMANIA CHAGASI; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; TREATMENT OUTCOME; VACCINATION; VISCERAL LEISHMANIASIS;

ANIMALS; BASE SEQUENCE; BRAZIL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; DNA, PROTOZOAN; DOG DISEASES; DOGS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LEISHMANIA INFANTUM; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MALE; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI;

EID: 77952547096     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.12.008     Document Type: Article

References (29)

1. Alvar J., Canãvate C., Molina R., Moreno J., Nieto J. Canine Leishmaniasis. Adv. Parasitol. 2004, 57:2-64.
2. ®. Vaccine 2009, 27:1008-1017.
3. Belkaid Y. The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin. Biol. Ther. 2003, 3:875-885.
4. Borja-Cabrera G.P., Da Silva V.O., Da Costa R.T., Reis A.B., Mayrink W., Genaro O., Palatnik C.B. The FML-ELISA assay in diagnosis and prognosis of canine visceral leishmaniasis. Am. J. Trop. Med. Hyg. 1999, 61:296-301.
5. Borja-Cabrera G.P., Correia Pontes N.N., Da Silva V.O., Paraguai De Souza E., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., Palatnik-De-Sousa C.B. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN). Vaccine 2002, 20:3277-3284.
6. Bourdoiseau G., Hugnet C., Gonçalves R.B., Vézilier F., Petit-Didier E., Papierok G., Lemesre J.L. Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs. Vet. Immunol. Immunopathol. 2009, 128:71-78.
7. Cabral M., ÓGrady J., Alexander J. Demonstration of Leishmania-specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 1992, 14:531-539.
8. Carrión J., Folgueira C., Alonso C. Immunization strategies against visceral leishmaniasis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells. Vaccine 2008, 26:2537-2544.
9. Da Silva V.O., Borja-Cabrera G.P., Correia Pontes N.N., De Souza E.P., Luz K.G., Palatnik M., Palatnik De Sousa C.B. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN). Vaccine 2001, 19:1082-1092.
10. Fernandez-Bellon H.P., Solano-Gallego L., Rodriguez A., Rutten V.P., Hoek A., Ramis A., Alberola J., Ferrer L. Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. Vet. Immunol. Immunopathol. 2005, 107:163-169.
11. Galkowska H., Waldemar L.O., Wojewodzka U. Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes. Vet. Immunol. Immunopathol. 1996, 53:329-334.
12. Garg R., Gupta S.K., Tripathi P., Hajela K., Sundar S., Naik S., Dube A. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis. Vaccine 2006, 24:2900-2909.
13. Gradoni L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Vet. Parasitol. 2001, 100:87-103.
14. Ikeda-Garcia F.A., Lopes R.S., Marques F.J., Lima V.M., Morinishi C.K., Bonello F.I., Zanette M.F., Perri S.H., Feitosa M.M. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet. Parasitol. 2007, 143:254-259.
15. Kurkjian K.M., Mahmutovic A.J., Kellar K.L., Haque R., Bern C., Secor W.E. Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis. Cytometry A 2006, 69:353-358.
16. Lima V.M.F., Gonçalves M.E., Ikeda F.A., Luvizotto M.C.R., Feitosa M.M. Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz. J. Med. Biol. Res. 2003, 36:485-489.
17. Murray H.W., Tsai C.W., Liu J., Ma X. Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18. Infect. Immun. 2006, 74:4370-4374.
18. Nogueira F.S., Moreira M.A., Borja-Cabrera G.P., Santos F.N., Menz I., Parra L.E., Xu Z., Chu H.J., Palatnik-de-Sousa C.B., Luvizotto M.C. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 2005, 23:4805-4810.
19. Nylén S., Maurya R., Eidsmo L., Manandhar K.D., Sundar S., Sacks D. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+ CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 2007, 4:805-817.
20. Palatnik C.B., Borojevic R., Previato J.O., Mendonca-Previato L. Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands. Infect. Immun. 1989, 57:754-763.
21. Palatnik-De-Sousa C.B., Dutra H.S., Borojevic R. Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose mannose ligant (FML). Acta Trop. 1993, 53:59-72.
22. Palatnik-De-Sousa C.B., Gomes E.M., Paraguai-De-Souza E., Palatnik M., Luz K., Borojevic R. Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis. Trans. Roy. Soc. Trop. Med. Hyg. 1995, 89:390-393.
23. Pinelli E., Gonzalo R.M., Boog C.J.P., Rutten V.P.M.G., Gebhard D., del Real G., Ruitenberg E.J. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. Eur. J. Immunol. 1995, 25:1594-1600.
24. Rodgers M.R., Popper S.J., Wirth D.F. Amplification of kinetoplast as tool in the detection and diagnosis of Leishmania. Exp. Parasitol. 1990, 71:267-275.
25. Rodrigues O.R., Marques C., Soares-Clemente M., Ferronha M.H., Santos-Gomes G.M. Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology 2009, 214:101-111.
26. Rutten I., Araújo M.S., de Andrade R.A., Vianna L.R., Mayrink W., Reis A.B., Sathler-Avelar R., Teixeira-Carvalho A., Andrade M.C., Mello M.N., Martins-Filho O.A. Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. Vaccine 2008, 26:2211-2224.
27. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold spring Harbor Laboratory Press, New York, pp. 9.16-9.19.
28. Stäger S., Maroof A., Zubairi S., Sanos S.L., Kopf M., Kaye P.M. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur. J. Immunol. 2006, 36:1764-1771.
29. White A.C., Castes M., Garcia L., Trujillo D., Zambrano L. Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection. Am. J. Trop. Med. Hyg. 1992, 46:123-131.